Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study

Neurobiology of Disease

Volumn 74, Issue , 2015, Pages 104-113

  Salvesen, Lisette ^a   Ullerup, Birgitte H ^a   Sunay, Fatma B ^a,b   Brudek, Tomasz ^a   Løkkegaard, Annemette ^a   Agander, Tina K ^c   Winge, Kristian ^a   Pakkenberg, Bente ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b BALIKESIR UNIVERSITY   (Turkey)

^c Rigshospitalet   (Denmark)

Author keywords

Basal ganglia; Glial cells; Multiple system atrophy; Neuronal loss; Red nucleus; Stereology

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; ASTROCYTE; BASAL GANGLION; BRAIN SIZE; CAUDATE NUCLEUS; CELL COUNT; CELL DENSITY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GLIOSIS; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; MALE; MICROGLIA; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PUTAMEN; REAL TIME POLYMERASE CHAIN REACTION; RED NUCLEUS; SHY DRAGER SYNDROME; STEREOLOGY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; METABOLISM; MIDDLE AGED; NERVE CELL; ORGAN SIZE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASTROCYTES; BASAL GANGLIA; CELL COUNT; FEMALE; HUMANS; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEURONS; OLIGODENDROGLIA; ORGAN SIZE; REAL-TIME POLYMERASE CHAIN REACTION; RED NUCLEUS; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 84913529632     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.11.008     Document Type: Article

References (51)

1. Ahmed Z., Asi Y.T., Sailer A., Lees A.J., Houlden H., Revesz T., Holton J.L. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol. Appl. Neurobiol. 2012, 38:4-24.
2. Balasingam V., Dickson K., Brade A., Yong V.W. Astrocyte reactivity in neonatal mice: apparent dependence on the presence of reactive microglia/macrophages. Glia 1996, 18:11-26.
3. Boyce R.W., Dorph-Petersen K.A., Lyck L., Gundersen H.J. Design-based stereology: introduction to basic concepts and practical approaches for estimation of cell number. Toxicol. Pathol. 2010, 38:1011-1025.
4. Brudek T., Winge K., Agander T.K., Pakkenberg B. Screening of Toll-like receptors expression in multiple system atrophy brains. Neurochem. Res. 2013, 38:1252-1259.
5. Bucher S.F., Seelos K.C., Dodel R.C., Paulus W., Reiser M., Oertel W.H. Pallidal lesions. Structural and functional magnetic resonance imaging. Arch. Neurol. 1996, 53:682-686.
6. Dickson D.W. Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect. Med. 2012, 2.
7. Fabricius K., Jacobsen J.S., Pakkenberg B. Effect of age on neocortical brain cells in 90+ year old human females-a cell counting study. Neurobiol. Aging 2013, 34:91-99.
8. Fellner L., Stefanova N. The role of glia in alpha-synucleinopathies. Mol. Neurobiol. 2013, 47:575-586.
9. Fujishiro H., Ahn T.B., Frigerio R., DelleDonne A., Josephs K.A., Parisi J.E., Eric A.J., Dickson D.W. Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?. Acta Neuropathol. 2008, 116:269-275.
10. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., Wood N.W., Colosimo C., Durr A., Fowler C.J., Kaufmann H., Klockgether T., Lees A., Poewe W., Quinn N., Revesz T., Robertson D., Sandroni P., Seppi K., Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
11. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 1987, 147:229-263.
12. Gundersen H.J., Osterby R. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J. Microsc. 1981, 121:65-73.
13. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
14. Gundersen H.J., Jensen E.B., Kieu K., Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J. Microsc. 1999, 193:199-211.
15. Hardman C.D., Halliday G.M. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov. Disord. 1999, 14:626-633.
16. Hardman C.D., Halliday G.M. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp. Neurol. 1999, 158:135-142.
17. Hardman C.D., Halliday G.M., McRitchie D.A., Cartwright H.R., Morris J.G. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata. Exp. Neurol. 1997, 144:183-192.
18. Hardman C.D., Halliday G.M., McRitchie D.A., Morris J.G. The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy. J. Neuropathol. Exp. Neurol. 1997, 56:132-142.
19. Ishizawa K., Komori T., Sasaki S., Arai N., Mizutani T., Hirose T. Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol. 2004, 63:43-52.
20. Ishizawa K., Komori T., Arai N., Mizutani T., Hirose T. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system). Neuropathology 2008, 28:249-257.
21. Jellinger K.A., Seppi K., Wenning G.K. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov. Disord. 2005, 20(Suppl. 12):S29-S36.
22. Karlsen A.S., Pakkenberg B. Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndrome-a stereological study. Cereb. Cortex 2011, 21:2519-2524.
23. Karlsen A.S., Korbo S., Uylings H.B., Pakkenberg B. A stereological study of the mediodorsal thalamic nucleus in Down syndrome. Neuroscience 2014, 279C:253-259.
24. Kato S., Shinozawa T., Takikawa M., Kato M., Hirano A., Awaya A., Ohama E. Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol. 2000, 100:481-489.
25. Kollensperger M., Geser F., Seppi K., Stampfer-Kountchev M., Sawires M., Scherfler C., Boesch S., Mueller J., Koukouni V., Quinn N., Pellecchia M.T., Barone P., Schimke N., Dodel R., Oertel W., Dupont E., Ostergaard K., Daniels C., Deuschl G., Gurevich T., Giladi N., Coelho M., Sampaio C., Nilsson C., Widner H., Sorbo F.D., Albanese A., Cardozo A., Tolosa E., Abele M., Klockgether T., Kamm C., Gasser T., Djaldetti R., Colosimo C., Meco G., Schrag A., Poewe W., Wenning G.K. Red flags for multiple system atrophy. Mov. Disord. 2008, 23:1093-1099.
26. Kreczmanski P., Heinsen H., Mantua V., Woltersdorf F., Masson T., Ulfig N., Schmidt-Kastner R., Korr H., Steinbusch H.W., Hof P.R., Schmitz C. Volume, neuron density and total neuron number in five subcortical regions in schizophrenia. Brain 2007, 130:678-692.
27. Lu C.S., Weng Y.H., Chen M.C., Chen R.S., Tzen K.Y., Wey S.P., Ting G., Chang H.C., Yen T.C. 99mTc-TRODAT-1 imaging of multiple system atrophy. J. Nucl. Med. 2004, 45:49-55.
28. Munoz E., Iranzo A., Rauek S., Lomena F., Gallego J., Ros D., Santamaria J., Tolosa E. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). J. Neurol. 2011, 258:2248-2253.
29. Nambu A., Chiken S., Shashidharan P., Nishibayashi H., Ogura M., Kakishita K., Tanaka S., Tachibana Y., Kita H., Itakura T. Reduced pallidal output causes dystonia. Front. Syst. Neurosci. 2011, 5:89.
30. O'Sullivan S.S., Massey L.A., Williams D.R., Silveira-Moriyama L., Kempster P.A., Holton J.L., Revesz T., Lees A.J. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008, 131:1362-1372.
31. Ozawa T., Paviour D., Quinn N.P., Josephs K.A., Sangha H., Kilford L., Healy D.G., Wood N.W., Lees A.J., Holton J.L., Revesz T. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004, 127:2657-2671.
32. Pakkenberg B., Gundersen H.J. Neocortical neuron number in humans: effect of sex and age. J. Comp. Neurol. 1997, 384:312-320.
33. Pakkenberg B., Moller A., Gundersen H.J., Mouritzen D.A., Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 1991, 54:30-33.
34. Pedersen K.M., Marner L., Pakkenberg H., Pakkenberg B. No global loss of neocortical neurons in Parkinson's disease: a quantitative stereological study. Mov. Disord. 2005, 20:164-171.
35. Pelvig D.P., Pakkenberg H., Stark A.K., Pakkenberg B. Neocortical glial cell numbers in human brains. Neurobiol. Aging 2008, 29:1754-1762.
36. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
37. Poewe W., Wenning G. The differential diagnosis of Parkinson's disease. Eur. J. Neurol. 2002, 9(Suppl. 3):23-30.
38. Probst-Cousin S., Rickert C.H., Schmid K.W., Gullotta F. Cell death mechanisms in multiple system atrophy. J. Neuropathol. Exp. Neurol. 1998, 57:814-821.
39. Qian L., Flood P.M., Hong J.S. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural Transm. 2010, 117:971-979.
40. Sigaard R.K., Kjaer M., Pakkenberg B. Development of the cell population in the brain white matter of young children. Cereb. Cortex 2014, [epub ahead of print], http://dx.doi.org/10.1093/cercor/bhu178.
41. Stefanova N., Reindl M., Neumann M., Kahle P.J., Poewe W., Wenning G.K. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 2007, 22:2196-2203.
42. Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 2010, 37:510-518.
43. Trojanowski J.Q., Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. Appl. Neurobiol. 2007, 33:615-620.
44. Wakabayashi K., Takahashi H. Cellular pathology in multiple system atrophy. Neuropathology 2006, 26:338-345.
45. Walloe S., Pakkenberg B., Fabricius K. Stereological estimation of total cell numbers in the human cerebral and cerebellar cortex. Front. Hum. Neurosci. 2014, 8:508.
46. Wenning G.K., Quinn N., Magalhaes M., Mathias C., Daniel S.E. "Minimal change" multiple system atrophy. Mov. Disord. 1994, 9:161-166.
47. Wenning G.K., Tison F., Ben S.Y., Daniel S.E., Quinn N.P. Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord. 1997, 12:133-147.
48. Wenning G.K., Seppi K., Tison F., Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J. Neural Transm. 2002, 109:307-320.
49. Wenning G.K., Stefanova N., Jellinger K.A., Poewe W., Schlossmacher M.G. Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol. 2008, 64:239-246.
50. West M.J. Introduction to stereology. Cold Spring Harb. Protoc. 2012, 8:843-851.
51. Yoshida M. Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 2007, 27:484-493.